期刊文献+

头颈部腺样囊性癌患者的预后及其影响因素分析 被引量:2

Prognosis and Risk Factors of Patients with Adenoid Cystic Carcinoma of the Head and Neck
下载PDF
导出
摘要 目的分析头颈部腺样囊性癌患者的预后及其影响因素。方法回顾性分析2004-2012年我院收治的55例头颈部腺样囊性癌患者的临床资料,其中单纯手术30例,手术加术后放疗22例,放化疗1例,单纯放疗2例,接受化疗15例。接受化疗的15例患者中初治后发生转移行化疗12例,术后同步化放疗2例,同期放化疗1例。采用Kaplan-Meier法和Logrank检验分析其临床疗效和预后情况。结果 55例患者的随访率为96%,中位随访时间46个月。3年、5年总生存率分别为89.8%、77.3%,无远处转移生存率分别为81.8%、35.9%,无局部区域失败生存率分别为79.1%、56.3%。单因素分析显示T分期、术后放疗和手术切缘与总生存率相关(P<0.05),手术切缘和术后放疗与无局部区域失败生存率相关(P<0.05)。多因素分析显示T分期是总生存率的独立影响因素(P=0.005),手术切缘是无局部区域失败生存率的独立影响因素(P=0.047)。结论头颈部腺样囊性癌治疗应尽量手术根治切除,局部晚期推荐手术及放疗综合治疗。 Objective To analyze the prognosis and influence factors of adenoid cystic carcinoma (ACC) of the head and neck. Methods The medical records of 55 patients diagnosed with ACC of the head and neck at our institution from 2004 to 2012 were reviewed. Of these patients, 30 received surgery alone, 22 received postoperative radiotherapy, one received radiotherapy and concurrent chemotherapy, and two received radiotherapy alone. Fifteen patients received chemotherapy, including palliative chemotherapy for 12 patients, post-operative concurrent chemotherapy for 2 patients and concurrent chemotherapy for one. The Kaplan-Meier method and the Log-rank method were applied to analyze the clinical effects and prognosis. Results The follow-up rate was 96%. The median follow-up was 46 months. The 3- and 5-year overall survival (OS) rates were respectively 89.8% and 77.3%, and the distant failure-free survival (DFFS) rates were respectively 81.8% and 35.9%. The 3- and 5-year locoregional failure-free survival (LRFFS) rates were 79.1% and 56.3%, respectively. Univariate analyses indicated that T-stage, postoperative radiotherapy and surgical margins were correlated with OS (P 〈 0.05). Surgical margins and postoperative radiotherapy were correlated with LRFFS (P〈 0.05). The multivariate analysis showed that T-stage was the independent risk factor for OS, and surgical margin was the independent risk factor for LRFFS. Conclusion The recommended treatment for advanced ACC is radical surgery and postoperative radiotherapy.
出处 《肿瘤药学》 CAS 2016年第4期275-280,共6页 Anti-Tumor Pharmacy
关键词 腺样囊性癌 头颈部 放射治疗 预后 Adenoid cystic carcinomas Head and neck Radiotherapy Prognostic factors
  • 相关文献

参考文献20

  • 1Agarwal JP, Jain S, Gupta T, et al. Intraoral adenoid cystic car-cinoma: prognostic factors and outcome [J]. Oral Oncol, 2008, 44(10): 986-993. doi: 10. 1016/j. oraloncology. 2008.01. 004.
  • 2李正江,唐平章,徐国镇,徐志坚.126例涎腺腺样囊性癌的疗效及预后因素[J].中华放射肿瘤学杂志,1999,8(4):204-207. 被引量:29
  • 3Shen C, Xu T, Huang C, et al. Treatment outcomes and prognostic features in adenoid cystic carcinoma origi- nated from the head and neck [J]. Oral Oncol, 2012, 48(5): 445-449. doi: 10. 1016/j. oraloncology. 2011.12. 002.
  • 4Shen CY, Xu T, Hu C, et al. Surgery alone or combined with postoperative radiotherapy for adenoid cystic carcinoma of the head and neck [J]. Int J Radiat Oncol Biol Phys, 2010, 78(3): $438-$439. doi: 10. 1016/j. ijrobp. 2010.07. 1031.
  • 5Balamucki C J, Amdur RJ, Werning JW, et al. Adenoid cystic carcinoma of the head and neck [J]. Am J Otolaryngol, 2012, 33(5): 510-518. doi: 10. 1016/j. amjoto. 2011.11. 006.
  • 6A1-Mamgani A, van Rooij P, Sewnaik A, et al. Adenoid cystic carcinoma of parotid gland treated with surgery and radiotherapy: long-term outcomes, QoL assessment and re- view of the literature [J]. Oral Oncol, 2012, 48(3): 278-283. doi: 10. lO16/j, oraloncology. 2011.10. 014.
  • 7Husain Q, Kanumuri VV, Svider PF, et al. Sinonasal adenoid cystic carcinoma: systematic review of survival and treatment strategies [J]. Curt Treat Options Oncol, 2005, 6(1): 3-18.
  • 8Li Q, Xn T, Gao JM, et al. Surgery alone provides long-term survival rates comparable to those of surgery plus postoper- ative radiotherapy for patients with adenoid cystic carcinoma of the palate [J]. Oral Oncol, 2011, 47(3): 170-173. doi: 10. 1016/j. oraloncology. 2010. 12. 005.
  • 9Lee SY, Kim BH, Choi EC. et al. Nineteen-year oncologic outcomes and the benefit of elective neck dissection in sali- vary gland adenoid cystic carcinoma [J]. Head Neck, 2014, 36(12): 1796-1801. doi: 10. lO02/hed. 23537.
  • 10贾婷婷,陶敬桥,魏丽萍,刘庆鹏,步荣发,席庆.放射粒子Ⅰ^(125)在颌面部腺样囊性癌治疗的临床观察[J].解放军医学院学报,2014,35(7):657-659. 被引量:5

二级参考文献35

  • 1刘文胜,唐平章,祁永发,高黎,李正江.腭部腺样囊性癌的诊治及预后因素的探讨[J].中华肿瘤杂志,2004,26(8):485-489. 被引量:27
  • 2胡效坤,王明友,杨志国,邱春东,吕东方,李晓东,左太阳.CT导引下经皮穿刺组织间植入^(125)I放射微粒子治疗中心型肺癌的应用研究[J].中华放射学杂志,2004,38(9):910-915. 被引量:117
  • 3史宏男,何荣根,邱蔚六,张伟国,徐宏波.nm23基因在涎腺腺样囊性癌中的表达及其与肺转移的关系[J].中华口腔医学杂志,1997,32(1):4-6. 被引量:13
  • 4FORDICE J, KERSHAW C, EL NAGGAR A, et al Adenoid cystic carcinoma of the head and neck: pre dictors of morbidity and mortality[J]. Arch Otolaryn gol Head Neck Surg, 1999, 125: 149-152.
  • 5SPIRO R H. Distant Metastasis in adenoid cystic car cinoma of salivaryorigin[J]. Am J Surg, 1997, 174: 495--498.
  • 6LUPINETTI A D, ROBERTS D B, WII.LIAMS M D, et al. Sinonasal adenoid cystic carcinoma., the M. D. Anderson Cancer Center experience[J]. Cancer, 2007, 110: 2726-2731.
  • 7GARDEN A S, WEBER R S, MORRISON W H, et al. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation[J]. Int J Radiat Oncol Biol Phys, 1995,32:619-626.
  • 8DULGUEROV P, JACOBSEN M S, ALLAL A S, et al. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a sys tematic review[J]. Cancer, 2001, 92:3012-3029.
  • 9KATZT S, MENDENHALL W M, MORRIS C G et al. Malignant tumors of the nasal cavity and para nasalsinuses[J]. Head Neck, 2002, 24: 821 -829.
  • 10Kim K H,Arch Otolaryngol Head Neck Surg,1994年,120卷,11期,1221页

共引文献37

同被引文献6

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部